
Cingulate rose 29.1% from $3.33 to $4.30, ahead of the S&P 500's +12.3%. Its worst day was Mar 18 (−31.0%), and its low came Nov 13 at $3.33.
Nov 13, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-1.35 missed the $-0.77 estimate on $0.00 revenue.
0.0% · S&P 500 −1.7%
Cingulate shares rose 16.9%, while the S&P 500 rose 0.4%.
+16.9% · S&P 500 +0.4%
Story events cover the past 12 months · Times ET
Cingulate shares rose 18.6%, while the S&P 500 rose 1.9%.
+18.6% · S&P 500 +1.9%
Cingulate shares rose 14.9%, while the S&P 500 fell 0.2%.
+14.9% · S&P 500 −0.2%
EPS of $-0.84 beat the $-1.15 estimate on $0.00 revenue.
−31.0%, the year's worst day · S&P 500 −1.4%
EPS of $-0.95 missed the $-0.53 estimate on $0.00 revenue.
−10.8% · S&P 500 +0.8%
Cingulate shares rose 21.1%, while the S&P 500 fell 0.7%.
+21.1% · S&P 500 −0.7%
EPS of $-0.45 beat the $-0.58 estimate on $0.00 revenue.
−4.2% · S&P 500 +0.7%
Where it ended: a close of $4.30 on Nov 13, 2026. Up next: Q3 2026 earnings on Nov 13, 2026 (EPS est. $-0.45, revenue est. $536,000.00).
Nothing in the past 12 months.
All CING dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CING and SPY from Benzinga historical bars. Not investment advice.